EDITORIAL
Editorial
Shichuo Li,
Corresponding Author
Shichuo Li
China Association Against Epilepsy, Beijing, China
Correspondence
Shichuo Li, China Association Against Epilepsy, Beijing, China.
Email: [email protected]
Search for more papers by this authorShichuo Li,
Corresponding Author
Shichuo Li
China Association Against Epilepsy, Beijing, China
Correspondence
Shichuo Li, China Association Against Epilepsy, Beijing, China.
Email: [email protected]
Search for more papers by this authorFirst published: 23 November 2022
No abstract is available for this article.
REFERENCES
- 1Cendes F. Epilepsy care in China and its relevance for other countries. Lancet Neurol. 2021; 20(5): 333-334.
- 2Ding D, Zhou D, Sander JW, Wang W, Li S, Hong Z. Epilepsy in China: major progress in the past two decades. Lancet Neurol. 2021; 20(4): 316-326.
- 3Charlson FJ, Baxter AJ, Cheng HG, Shidhaye R, Whiteford HA. The burden of mental, neurological, and substance use disorders in China and India: a systematic analysis of community representative epidemiological studies. Lancet. 2016; 388(10042): 376-389.
- 4Yu P, Zhou D, Liao W, et al. An investigation of the characteristics of outpatients with epilepsy and antiepileptic drug utilization in a multicenter cross-sectional study in China. Epilepsy Behav. 2017; 69: 126-132.
- 5Ge Y, Yu P, Ding D, et al. Etiologic features and utilization of antiepileptic drugs in people with chronic epilepsy in China: report from the epilepsy cohort of Huashan hospital (ECoH). Epilepsy Res. 2015; 116: 99-104.
- 6Liu T, Chen F, Zhai F, Liang S. Progress of clinical research studies on tuberous sclerosis complex-related epilepsy in China. Acta Neurol Scand. 2022; 146(6): 743-751.
10.1111/ane.13692 Google Scholar
- 7Li G, Liu X, Yu T, Ren J, Wang Q. Positron emission tomography in autoimmune encephalitis: clinical implications and future directions. Acta Neurol Scand. 2022; 146(6): 708-715.
10.1111/ane.13717 Google Scholar
- 8Tang C, Yang W, Luan G. Progress in pathogenesis and therapy of Rasmussen's encephalitis. Acta Neurol Scand. 2022; 146(6): 761-766.
- 9Gao K, Lin Z, Wen S, Jiang Y. Potassium channels and epilepsy. Acta Neurol Scand. 2022; 146(6): 699-707.
10.1111/ane.13695 Google Scholar
- 10Zhao C, Lu L, Liu W, Zhou D, Wu X. Complementary and alternative medicine for treating epilepsy in China: a systematic review. Acta Neurol Scand. 2022; 146(6): 775-785.
- 11Xue T, Chen S, Bai Y, Han C, Yang A, Zhang J. Neuromodulation in drug-resistant epilepsy: a review of current knowledge. Acta Neurol Scand. 2022; 146(6): 786-797.
10.1111/ane.13696 Google Scholar
- 12Yan H, Ren L, Yu T. Deep brain stimulation of the subthalamic nucleus for epilepsy. Acta Neurol Scand. 2022; 146(6): 798-804.
- 13Wang X, Yang F, Chen B, Jiang W. Non-convulsive seizures and non-convulsive status epilepticus in neuro-intensive care unit. Acta Neurol Scand. 2022; 146(6): 752-760.
- 14Ye L, Xu J, Chen C, Zhang L, Wang S. Effects of anti-seizure therapies on sleep in patients with epilepsy: a literature review. Acta Neurol Scand. 2022; 146(6): 767-774.
10.1111/ane.13699 Google Scholar
- 15Gong Y, Xu C, Wang S, Wang Y, Chen Z. Computerized application for epilepsy in China: does the era of artificial intelligence comes? Acta Neurol Scand. 2022; 146(6): 732-742.
10.1111/ane.13711 Google Scholar
- 16Li W, Wang G, Lei X, Sheng D, Yu T, Wang G. Seizure detection based on wearable devices: a review of device, mechanism, and algorithm. Acta Neurol Scand. 2022; 146(6): 723-731.
- 17 International Bureau for Epilepsy. Annual Report 2005; 2005. Accessed October 16, 2022. https://www.ibe-epilepsy.org/annual-report-2005-2/
